Medications
Czechs report record fake erectile pills seizure
Customs officials in the Czech Republic say they have seized almost 200,000 fake erectile dysfunction pills.
Sep 24, 2013
0
0
Page 11 - News tagged with eli lilly
Medications
Scientists create extremely potent and improved derivatives of successful anticancer drug
Scientists at The Scripps Research Institute (TSRI) have found a way to make dramatic improvements to the cancer cell-killing power of vinblastine, one of the most successful chemotherapy drugs of the past few decades. The ...
Sep 16, 2013
0
1
Medical research
Hormone may help fight obesity and reduce cholesterol
Research has shown that giving obese rodents a recently identified circulating protein called fibroblast growth factor 21 (FGF21) helps improve their metabolism. Now investigators reporting in the Cell Press journal Cell ...
Sep 3, 2013
1
0
Diabetes
Italian study shows gender disparity in diabetes care
(HealthDay)—Compared to Italian men, women in Italy receive a poorer quality of diabetes care, and although difficulty attaining an ideal low-density lipoprotein cholesterol (LDL-C) level appears to be mostly related to ...
Aug 8, 2013
0
0
Alzheimer's disease & dementia
Medicare won't pay for Eli Lilly Alzheimer's agent
Eli Lilly & Co. says it will push ahead with a first-of-a-kind imaging chemical designed to help screen for Alzheimer's disease, despite a negative ruling by Medicare officials.
Jul 8, 2013
0
0
Diseases, Conditions, Syndromes
Duloxetine moderately cost-effective for treating back pain
(HealthDay)—Duloxetine is a moderately cost-effective treatment for chronic low back pain (CLBP) compared with other post-first-line oral medications, according to research published in the May 15 issue of Spine.
Jun 14, 2013
0
0
Medications
Lilly stops mid-stage Alzheimer's drug study (Update)
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.
Jun 13, 2013
0
0
Oncology & Cancer
Comprehensive analysis supports SERMs for cutting breast cancer
(HealthDay)—Treatment with selective estrogen receptor modulators (SERMs) is associated with a significant reduction in the incidence of breast cancer, especially for the first five years after treatment, according to research ...
Apr 30, 2013
0
0
Alzheimer's disease & dementia
Lilly drug chosen for Alzheimer's prevention study (Update)
Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study testing whether it's possible to prevent Alzheimer's disease in older people at high risk of developing it.
Jan 18, 2013
0
0
Diabetes
Insulin LY2605541 tops glargine for glycemic control in T1DM
(HealthDay)—For patients with type 1 diabetes, the novel, long-acting basal insulin LY2605541 yields greater improvement in glycemic control compared with insulin glargine, according to a study published online Nov. 27 ...
Jan 13, 2013
0
0
